The last two decades have seen a huge change in society’s collective perspective on drugs. Surprisingly, even traditionally taboo drugs like psychedelics have slowly become accepted in some parts of the world. Some party drugs like ketamine and MDMA are even being respected as therapeutic drugs.
This sudden shift can be seen in the legalization of marijuana in different states, and countries around the world. Just a short while ago, marijuana was in the eyes of the society, a drug used by lazy, idle people and drug addicts. That image has now almost been fully erased and replaced with that of a known prescription medicine.
Interestingly, some of the drugs which were not considered dangerous in the past are now slowly losing popularity especially with the youth. An example can be given of the increase in alcohol-free beers. Alcohol use has declined with many people reducing the amount of alcohol they consume while some have quit drinking altogether.
Caffeine, which for a long time was not considered a drug, is recently beginning to spark a different opinion in users. People have realized that caffeine is actually an addictive drug and the addiction to coffee is no longer a surprising condition. This has led to many coffee users cutting back on their coffee intake.
Sugar is another good example of substances that had not until very recently been considering to be drugs. The growing societal view of sugar as a drug is set to grow in coming years just like that of coffee.
One of the main reasons we can attribute to this sudden change in attitudes towards drugs is the promotion of physical and mental health in recent years with the general term ‘wellness’. Some drugs like psychedelics have been found to be therapeutic thereby attracting former non-users.
A bigger contribution to this change has been made by advanced scientific research on drugs in recent years. A perfect example would be a research by the Neuroscience & Biobehavioral Reviews on sugar. This report finds that as pervasive as sugar is, it meets the criteria to be an abused substance and is addictive to binge users.
Nootropics as a new category of drugs has also played a significant role in the societal acceptance of previously outlawed drugs. This is a category that comprises of all performance drugs that improve human body functions. It therefore comprises of a wide range of drugs from coffee, magic mushrooms to drugs like modafinil.
This trend is likely to continue in the future, especially for psychedelics. Traditionally accepted drugs like tobacco will probably eventually be outlawed as people learn the health benefits of psychedelics.
Experts say that these changes in attitude may be giving psychedelic companies like Numinus Wellness Inc. (TSX.V: NUMI) added impetus to invest more in R&D.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.